Physician profile
Garret M Wobst
NPI 1124376389
$78,920.49
in general payments reported to CMS, 2019-2025
17 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,135 · 2020: $3,401 · 2021: $9,075 · 2022: $7,187 · 2023: $19K · 2024: $14K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Travel and Lodging: $8,244 · Honoraria: $3,750 · Food and Beverage: $3,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,925.00 |
| Travel and Lodging | $8,244.35 |
| Honoraria | $3,750.00 |
| Food and Beverage | $3,203.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $21,280.10 | 2021-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Hybrid |
| Trilliant Surgical LLC. | $19,889.55 | 2019-2025 | Arsenal Ankle, Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Linvatec Corporation | $10,640.19 | 2023-2025 | Quantum, Biobrace 23mm, Hercules Suture Anchor System |
| Smith+Nephew, INC. | $7,524.64 | 2019-2025 | Stravix, Cadence |
| Stryker Corporation | $4,956.37 | 2021-2025 | Prophecy, Invision, Inbone |
| Arthrex, INC. | $4,348.51 | 2019-2022 | |
| In2bones USA, LLC | $3,913.15 | 2020-2022 | |
| Integra Lifesciences Corporation | $3,370.14 | 2019-2020 | |
| Sioux Surgical INC | $1,213.89 | 2022-2023 | |
| Paragon 28, INC. | $583.13 | 2023-2025 | Apex 3d, Portfolio |
| Novastep INC. | $500.00 | 2024 | Airlock Centrolock, Nexis |
| Rsw Medical Company, INC. | $338.28 | 2019 | |
| Encore Medical, Lp | $196.76 | 2021 | |
| Organogenesis INC. | $114.77 | 2019-2022 | |
| Osiris Therapeutics INC. | $29.75 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.64 | 2020 | |
| Kerecis Limited | $8.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garret Wobst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.